Reproductive Corticotropin Releasing Hormone, Implantation, and Fetal Immunotolerance

REFERENCES

• Makrigiannakis A, Minas V, Kalantaridou S N, Nikas G, Chrousos G P. Hormonal and cytokine regulation of early implantation. Trends Endocrinol Metab 2006; 17: 178–185
   PubMed Web of Science ®Google Scholar
• Makrigiannakis A, Margioris A N, Le Goascogne C, Zoumakis E, Nikas G, Stournaras G, Psychoyos A, Gravanis A. Corticotropin-releasing hormone (CRH) is expressed at the implantation sites of early pregnant rat uterus. Life Sci 1995; 57: 1869–1875
   Google Scholar
• Gill T J, 3rd. Immunological and genetic factors influencing pregnancy and development. Am J Reprod Immunol Microbiol 1986; 10: 116–120
   Google Scholar
• Makrigiannakis A, Zoumakis E, Kalantaridou S, Coutifaris C, Margioris A N, Coukos G, Rice K C, Gravanis A, Crousos G P. Corticotropin-releasing hormone promotes blastocyst implantation and early maternal tolerance. Nat Immunol 2001; 2: 1018–1024
   PubMed Web of Science ®Google Scholar
• Nagata S. Fas and Fas ligand: a death factor and its receptor. Adv Immunol 1994; 57: 129–144
   PubMed Web of Science ®Google Scholar
• Suda T, Okazaki T, Naito Y, Yokota T, Arai N, Ozaki S, Nakao K, Nagata S. Expression of the Fas ligand in cells of T cell lineage. J Immunol 1995; 154: 3806–3813
   PubMed Web of Science ®Google Scholar
• Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, Duke R C. A role for CD95 ligand in preventing graft rejection. Nature 1995; 377: 630–632
   PubMed Web of Science ®Google Scholar
• Griffith T S, Yu X, Herndon J M, Green D R, Ferguson T A. CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance. Immunity 1996; 5: 7–16
   PubMed Web of Science ®Google Scholar
• Runic R, Lockwood C J, Ma Y, Dipasquale B, Guller S. Expression of Fas ligand by human cytotrophoblasts: implications in placentation and fetal survival. J Clin Endocrinol Metab 1996; 81: 3119–3122
   PubMedGoogle Scholar
• Nagata S. Apoptosis by death factor. Cell 1997; 88: 355–365
   PubMed Web of Science ®Google Scholar
• Huang D C, Hahne M, Schroeter M, Frei K, Fontana A, Villanger A, Newton K, Tschopp J, Strasser A. Activation of Fas by Fasl induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-x(L). Proc Natl Acad Sci USA 1999; 96: 14871–14876
   PubMed Web of Science ®Google Scholar
• Bamberger A M, Schulte H M, Thuneke I, Erdmann I, Bamberger C M, Asa S L. Expression of the apoptosis-inducing Fas ligand (FasL) in human first and third trimester placenta and choriocarcinoma cells. J Clin Endocrinol Metab 1997; 82: 3173–3175
   PubMed Web of Science ®Google Scholar
• Grino M, Chrousos G P, Margioris A N. The corticotropin releasing hormone gene is expressed in human placenta. Biochem Biophys Res Commun 1987; 148: 1208–1214
   PubMed Web of Science ®Google Scholar
• Frim D M, Emanuel R L, Robinson B G, Smas C M, Adler G K, Majzoub J A. Characterization and gestational regulation of corticotropin-releasing hormone messenger RNA in human placenta. J Clin Invest 1988; 82: 287–292
   PubMed Web of Science ®Google Scholar
• Jones S A, Brooks A N, Challis J R. Steroids modulate corticotropin-releasing hormone production in human fetal membranes and placenta. J Clin Endocrinol Metab 1989; 68: 825–830
   PubMed Web of Science ®Google Scholar
• Petraglia F, Tabanelli S, Galassi M C, Garuti G C, Mancini A C, Genazzani A R, Gurpide E. Human decidua and in vitro decidualized endometrial stromal cells at term contain immunoreactive corticotropin-releasing factor (CRF) and CRF-messenger ribonucleic acid. J Clin Endocrinol Metab 1992; 74: 1427–1431
   PubMed Web of Science ®Google Scholar
• Makrigiannakis A, Zoumakis E, Margioris A N, Theodoropoulos P, Stournaras C, Gravanis A. The corticotropin-releasing hormone (CRH) in normal and tumoral epithelial cells of human endometrium. J Clin Endocrinol Metab 1995; 80: 185–189
   PubMedGoogle Scholar
• Mastorakos G, Scopa C D, Kao L C, Vryonidou A, Friedman T C, Kattis D, Phenekos C, Rabin D, Chrousos G P. Presence of immunoreactive corticotropin-releasing hormone in human endometrium. J Clin Endocrinol Metab 1996; 81: 1046–1050
   Google Scholar
• Chrousos G P, Torpy D J, Gold P W. Interactions between the hypothalamic-pituitary-adrenal axis and the female reproductive system: clinical implications. Ann Intern Med 1998; 129: 229–240
   PubMedGoogle Scholar
• Clifton V L, Telfer J F, Thompson A J, Cameron I T, Teoh T G, Lye S J, Challis J R. Corticotropin-releasing hormone and proopiomelanocortin-derived peptides are present in human myometrium. J Clin Endocrinol Metab 1998; 83: 3716–3721
   PubMedGoogle Scholar
• Rogers P A. Early endometrial microvascular response during implantation in the rat. Reprod Fertil Dev 1992; 4: 261–264
   Google Scholar
• Psychoyos A, Nikas G, Gravanis A. The role of prostaglandins in blastocyst implantation. Hum Reprod 1995; 10: 30–42
   Google Scholar
• Chrousos G P, Schulte H M, Oldfield E H, Gold P W, Cutler G B, Jr., Loriaux D L. The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome. N Engl J Med 1984; 310: 622–626
   Google Scholar
• Karalis K, Sano H, Redwine J, Listwak S, Wilder R L, Chrousos G P. Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science 1991; 254: 421–423
   PubMed Web of Science ®Google Scholar
• Webster E L, Lewis D B, Torpy D J, Zachman E K, Rice K C, Chrousos G P. In vivo, in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation. Endocrinology 1996; 137: 5747–5750
   PubMed Web of Science ®Google Scholar
• Udelsman R, Gallucci W T, Bacher J, Loriaux D L, Chrousos G P. Hemodynamic effects of corticotropin-releasing hormone in the anesthetized cynomolgus monkey. Peptides 1986; 7: 465–471
   Google Scholar
• Theoharides T C, Singh L K, Boucher W, Pang X, Letournau R, Webster E, Chrousos G. Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects. Endocrinology 1998; 139: 403–413
   PubMed Web of Science ®Google Scholar
• Chrousos G P, Gold P W. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA 1992; 267: 1244–1252
   PubMed Web of Science ®Google Scholar
• Vale W, Spiess J, Rivier C, Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and β -endorphin. Science 1981; 213: 1394–1397
   PubMed Web of Science ®Google Scholar
• Vale W, Rivier C, Brown M R, Spiess J, Koob G, Swanson L. Chemical and biological characterization of corticotropin releasing factor. Recent Prog Horm Res 1983; 39: 245–270
   PubMedGoogle Scholar
• Antoni F A. Hypothalamic control of adrenocorticotropin secretion: advances since the discovery of 41-residue corticotropin-releasing factor. Endocr Rev 1986; 7: 351–378
   PubMed Web of Science ®Google Scholar
• Orth D N. Corticotropin-releasing hormone in humans. Endocr Rev 1992; 13: 164–191
   PubMed Web of Science ®Google Scholar
• Petrusz P, Merchenthaler I, Maderdrut L, Vigh S, Schally A V. Corticotropin-releasing factor (CRF)-like immunoreactivity in the vertebrate endocrine pancreas. Proc Natl Acad Sci USA 1983; 80: 1721–1725
   PubMed Web of Science ®Google Scholar
• Suda T, Tomori N, Tozawa F, Mouri T, Demoura H, Shizume K. Distribution and characterization of immunoreactive corticotropin-releasing factor in human tissues. J Clin Endocrinol Metab 1984; 59: 861–866
   PubMedGoogle Scholar
• Petrusz P, Merchenthaler I, Ordronneau P, Maderdrudt J L, Vigh S, Schally A V. Corticotropin-releasing factor-like immunoreactivity in the gastro-entero-pancreatic endocrine system. Peptides 1984; 5: S71–S78, (Suppl 1)
   PubMed Web of Science ®Google Scholar
• Usui T, Nakai Y, Tsukada T, Jingami H, Takahashi H, Fukada J, Imura H. Expression of adrenocoricotropin-releasing hormone precursor gene in placenta and other nonhypothalamic tissues in man. Mol Endocrinol 1988; 2: 871–875
   Google Scholar
• Dammrich J, Ormanns W, Kahaly G, Schrezenmeir J. Multiple peptide hormone producing adenocarcinoma of lung with neurotensin and CRF-like immunoreactivity. Pathol Res Pract 1988; 183: 670–674
   PubMed Web of Science ®Google Scholar
• Owens M J, Nemeroff C B. Physiology and pharmacology of corticotropin-releasing factor. Pharmacol Rev 1991; 43: 425–73
   PubMed Web of Science ®Google Scholar
• Donaldson C J, Sutton S W, Perrin M H, Corrigan A Z, Lewis K A, Rivier J E, Vaughan J M, Vale W W. Cloning and characterization of human urocortin. Endocrinology 1996; 137: 2167–2170
   PubMed Web of Science ®Google Scholar
• Zoumakis E, Grammatopoulos D K, Chrousos G P. Corticotropin-releasing hormone receptor antagonists. Eur J Endocrinol 2006; 155: S58–S91, (Suppl-1)
   Google Scholar
• Grammatopoulos D K, Chrousos G P. Functional characteristics of CRH receptors and potential clinical applications of CRH receptor antagonists. Trends Endocrinol Metab 2002; 13: 436–444
   PubMed Web of Science ®Google Scholar
• Smets G, Van Gompel J, Meyer C, Abs R, de Menten Y, Kloppel G. Corticotropin-releasing hormone receptors on human pituitary cells: autoradiography at the light microscopical level, quantification and immunohistochemistry. Prog Histochem Cytochem 1992; 26: 107–109
   Google Scholar
• Hillhouse E W, Grammatopoulos D, Milton N G, Quartero H W. The identification of a human myometrial corticotropin-releasing hormone receptor that increases in affinity during pregnancy. J Clin Endocrinol Metab 1993; 76: 736–741
   PubMedGoogle Scholar
• Grigoriadis D E, Heroux J A, De Souza E B. Characterization and regulation of corticotropin-releasing factor receptors in the central nervous, endocrine and immune system. Ciba Found Symp 1993; 172: 85–101, discussion 101–107
   Google Scholar
• Chang C P, Pearse R V, II, O'Connell S, Rosenfeld M G. Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain. Neuron 1993; 11: 1187–1195
   PubMed Web of Science ®Google Scholar
• Chen R, Lewis K A, Perrin M H, Vale W W. Expression cloning of a human corticotropin-releasing factor receptor. Proc Natl Acad Sci USA 1993; 90: 8967–8971
   PubMed Web of Science ®Google Scholar
• Polymeropoulos M H, Torres R, Yanovski J A, Chandrasekharappa S C, Ledbetter D H. The human corticotropin-releasing factor receptor (CRHR) gene maps to chromosome 17q12-q22. Genomics 1995; 28: 123–124
   PubMed Web of Science ®Google Scholar
• Xiong Y, Xie L, Abou-Samra A B. Signaling properties of mouse and human corticotropin-releasing factor (CRF) receptors: decreased coupling efficiency of human type II CRF receptor. Endocrinology 1995; 136: 1828–1834
   Google Scholar
• Perrin M, Donaldson C, Chen R, Blount A, Berggren T, Bilezikjian L, Sawchenko P, Vale W. Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart. Proc Natl Acad Sci USA 1995; 92: 2969–2973
   PubMed Web of Science ®Google Scholar
• Kishimoto T, Pearse R V, II, Lin C R, Rosenfeld M G. A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle. Proc Natl Acad Sci USA 1995; 92: 1108–1112
   PubMed Web of Science ®Google Scholar
• Lovenberg T W, Liaw C W, Grigoriadis D E, Clevenger W, Chalmers D T, De Souza E B, Oltersdorf T. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc Natl Acad Sci USA 1995; 92: 836–840
   PubMed Web of Science ®Google Scholar
• Chrousos G P. Reproductive placental corticotropin-releasing hormone and its clinical implications. Am J Obstet Gynecol 1999; 180: 249S–250S, (Suppl I–III)
   Google Scholar
• Ferin M. The menstrual cycle: an integrative view. Reproductive Endocrinology, Surgery and Technology, E Y Adashi, J A Rock, Z Rosenwaks. Lippincott, Philadelphia 1996; Vol. 1: 103–121
   Google Scholar
• Chen M D, O'Byrne K T, Chiappini S E, Hotchkiss J, Knobil E. Hypoglycemic “stress” and gonadotropin-releasing hormone pulse generator activity in the rhesus monkey: role of the ovary. Neuroendocrinology 1992; 56: 666–673
   PubMed Web of Science ®Google Scholar
• Sakakura M, Takebe K, Nakagawa S. Inhibition of luteinizing hormone secretion induced by synthetic LRH by long-term treatment with glucocorticoids in human subjects. J Clin Endocrinol Metab 1975; 40: 774–779
   PubMed Web of Science ®Google Scholar
• Rabin D S, Johnson E O, Brandon D D, Liapi C, Chrousos G P. Glucocorticoids inhibit estradiol-mediated uterine growth: possible role of the uterine estradiol receptor. Biol Reprod 1990; 42: 74–80
   PubMed Web of Science ®Google Scholar
• Vamvakopoulos N C, Chrousos G P. Evidence of direct estrogenic regulation of human corticotropin-releasing gene expression. Potential implications for the sexual dimorphism of the stress response and immune/inflammatory reaction. J Clin Invest 1993; 92: 1896–1902
   PubMed Web of Science ®Google Scholar
• Fourestie V, De Lignieres B, Roudot-Thoraval F, Fulli-Lemaire I, Cremniter D, Nahoul K, Fournier S, Lejonc J L. Suicide attempts in hypo-estrogenic phases of the menstrual cycle. Lancet 1986; 2: 1357–1360
   PubMed Web of Science ®Google Scholar
• Skobeloff E M, Spivey W H, Silverman R, Eskin B A, Harchelroad F, Alessi T V. The effect of the menstrual cycle on asthma presentations in the emergency department. Arch Intern Med 1996; 156: 1837–1840
   PubMed Web of Science ®Google Scholar
• Chrousos G P. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995; 332: 1351–1362
   PubMed Web of Science ®Google Scholar
• Mastorakos G, Webster E, Friedman T C, Chrousos G P. Immunoreactive corticotropin-releasing hormone and its binding in the rat ovaries. J Clin Invest 1993; 92: 961–968
   PubMedGoogle Scholar
• Mastorakos G, Scopa C, Vryonidou A, Friedman T C, Kattis D, Phenekos C, Merino M J, Chrousos G P. Presence of immunoreactive corticotropin-releasing hormone in normal and polycystic human ovaries. J Clin Endocrinol Metab 1994; 79: 1191–1197
   PubMed Web of Science ®Google Scholar
• Asakura H, Zwain I H, Yen S S. Expression of genes encoding corticotropin-releasing factor (CRF), type 1 CRF receptor, and CRF-binding protein and localization of the gene products in the human ovary. J Clin Endocrinol Metab 1997; 82: 2720–2725
   PubMed Web of Science ®Google Scholar
• Calogero A E, Burrello N, Negri-Cesi P, Papale L, Palumbo M A, Cianci A, Sanfilippo S, D'Agata R. Effects of corticotropin-releasing hormone on ovarian estrogen production in vitro. Endocrinology 1996; 137: 4161–4166
   PubMed Web of Science ®Google Scholar
• Ghizzoni L, Mastorakos G, Vottero A, Barreca A, Furlini M, Cesarone A, Ferrari B, Chrousos G P, Bernasconi S. Corticotropin-releasing hormone (CRH) inhibits steroid biosynthesis by cultured human granulosa-lutein cells in a CRH and interleukin-1 receptor-mediated fashion. Endocrinology 1997; 138: 4806–4811
   PubMed Web of Science ®Google Scholar
• Bromberger J T, Matthews K A, Kuller L H, Wing R R, Meilahn E N, Plantinga P. Prospective study of the determinants of age at menopause. Am J Epidemiol 1997; 145: 124–133
   PubMed Web of Science ®Google Scholar
• Zoumakis E, Chatzaki E, Charalampopoulos I, Margioris A N, Angelakis E, Koumantakis E, Gravanis A. Cycle and age-related changes in corticotropin-releasing hormone levels in human endometrium and ovaries. Gynecol Endocrinol 2001; 15: 98–102
   PubMed Web of Science ®Google Scholar
• Mastorakos G, Scopa C D, Kao L C, Vryonidou A, Friedman T C, Kattis D, Phenekos C, Rabin D, Chrousos G P. Presence of immunoreactive corticotropin-releasing hormone in human endometrium. J Clin Endocrinol Metab 1996; 81: 1046–1050
   Google Scholar
• Di Blasio A M, Pecori Giraldi F, Vigano P, Petraglia F, Vignali M, Cavagnini F. Expression of corticotropin-releasing hormone and its R1 receptor in human endometrial stromal cells. J Clin Endocrinol Metab 1997; 82: 1594–1597
   PubMed Web of Science ®Google Scholar
• Grammatopoulos D, Milton N G, Hillhouse E W. The human myometrial CRH receptor: G proteins and second messengers. Mol Cell Endocrinol 1994; 99: 245–250
   PubMedGoogle Scholar
• Grammatopoulos D, Thompson S, Hillhouse E W. The human myometrium express multiple isoforms of the corticotropin-releasing hormone receptor. J Clin Endocrinol Metab 1995; 80: 2388–2393
   PubMed Web of Science ®Google Scholar
• Grammatopoulos D, Stirrat G M, Williams S A, Hillhouse E W. The biological activity of the corticotropin-releasing hormone receptor-adenylate cyclate complex in human myometrium is reduced at the end of pregnancy. J Clin Endocrinol Metab 1996; 81: 745–751
   PubMed Web of Science ®Google Scholar
• Makrigiannakis A, Zoumakis E, Margioris A N, Stournaras C, Chrousos G P, Gravanis A. Regulation of the promoter of the human corticotropin-releasing hormone gene in transfected human endometrial cells. Neuroendocrinology 1996; 64: 85–92
   PubMed Web of Science ®Google Scholar
• Makrigiannakis A, Psychoyos A, Zoumakis E, Margioris A N, Stournaras C, Gravanis A. Endometrial corticotropin-releasing hormone: expression, regulation, and potential psychological implications. Ann NY Acad Sci 1997; 816: 116–128
   PubMedGoogle Scholar
• Makrigiannakis A, Margioris A N, Zoumakis E, Stournaras C, Garvanis A. The transcription of corticotropin-releasing hormone in human endometrial cells is regulated by cytokines. Neuroendocrinology 1999; 70: 451–459
   PubMedGoogle Scholar
• Ferrari A, Petraglia F, Gurpide E. Corticotropin-releasing factor decidualizes human endometrial stromal cells in vitro. Interaction with progestin. J Steroid Biochem Mol Biol 1995; 54: 251–255
   PubMed Web of Science ®Google Scholar
• Zoumakis E, Margioris A N, Stournaras C, Dermitzaki E, Angelakis E, Makrigiannakis A, Koumantakis E, Gravanis A. Corticotropin-releasing hormone (CRH) interacts with inflammatory prostaglandins and interleukins and affects decidualization of human endometrial stroma. Mol Hum Reprod 2000; 6: 344–351
   PubMedGoogle Scholar
• Petraglia F, Tabanelli S, Galassi M C, Garuti G C, Mancini A C, Genazzani A R, Gurpide E. Human decidua and in vitro decidualized endometrial cells at term contain immunoreactive CRF and CRF mRNA. J Clin Endocrinol Metab 1992; 74: 1427–1431
   PubMed Web of Science ®Google Scholar
• Frank G R, Brar A K, Jikihara H, Cedars M I, Handwerger S. Interleukin-1 beta and the endometrium: an inhibitor of stromal cell differentiation and possible autoregulator of decidualization in humans. Biol Reprod 1995; 52: 184–191
   PubMed Web of Science ®Google Scholar
• Makrigiannakis A, Margioris A N, Chatzaki E, Zoumakis E, Chrousos G P, Gravanis A. The decidualizing effect of progesterone may involve direct transcriptional activation of corticotrophin-releasing hormone from human endometrial stromal cells. Mol Hum Reprod 1999; 5: 789–796
   PubMedGoogle Scholar
• Sheth K V, Roca G L, al-Sedairy S T, Parhar R S, Hamilton C J, al-Abdul Jabbar F. Prediction of successful embryo implantation by measuring interleukin-1-alpha and immunosuppressive factor(s) in preimplantation embryo culture fluid. Fertil Steril 1991; 55: 952–957
   PubMed Web of Science ®Google Scholar
• Lass A, Weiser W, Munafo A, Loumaye E. Leukemia inhibitory factor in human reproduction. Fertil Steril 2001; 76: 1091–1096
   PubMed Web of Science ®Google Scholar
• Kauma S W, Huff T F, Hayes N, Nilkaeo A. Placental Fas ligand expression is a mechanism for maternal immune tolerance to the fetus. J Clin Endocrinol Metab 1999; 84: 2188–2194
   PubMed Web of Science ®Google Scholar
• McIntyre J A, Faulk W P. Trophoblast antigens in normal and abnormal human pregnancy. Clin Obstet Gynecol 1986; 29: 976–998
   Google Scholar
• Martin J N, Jr., Perry K G, Jr., Miles J F, Jr., Blake P G, Magann E F, Roberts W E, Martin R W. The interrelationship of eclampsia, HELLP syndrome, and prematurity: cofactors for significant maternal and perinatal risk. Br J Obstet Gynaecol 1993; 100: 1095–1100
   PubMedGoogle Scholar
• Athanassakis I, Farmakiotis V, Papadimitriou L. Uterine cytokine production during the menstrual cycle and preimplantation stages in mice. Dev Immunol 1999; 7: 33–42
   Google Scholar
• Psychoyos A. Uterine receptivity for nidation. Ann NY Acad Sci 1986; 476: 36–42
   PubMed Web of Science ®Google Scholar
• Muglia L, Jacobson L, Dikkes P, Majzoub J A. Corticotropin-releasing hormone deficiency reveals major fetal but not adult glucocorticoid need. Nature 1995; 373: 427–432
   PubMed Web of Science ®Google Scholar
• Turnbull A V, Smith G W, Lee S, Vale W W, Lee K F, Rivier C. CRF type I receptor-deficient mice exhibit a pronounced pituitary-adrenal response to local inflammation. Endocrinology 1999; 140: 1013–1017
   PubMed Web of Science ®Google Scholar
• Abrahams V M, Straszweski-Chavez S L, Guller S, Mor G. First trimester trophoblast cells secrete Fas ligand which induces immune cell apoptosis. Mol Hum Reprod 2004; 10: 55–63
   PubMed Web of Science ®Google Scholar
• Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y, Nagata S. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991; 66: 233–243
   PubMed Web of Science ®Google Scholar
• Yamashita H, Otsuki Y, Matsumoto K, Ueki K, Ueki M. Fas ligand, Fas antigen and Bcl-2 expression in human endometrium during the menstrual cycle. Mol Hum Reprod 1999; 5: 358–364
   PubMedGoogle Scholar
• Phillips T A, Ni J, Pan G, Ruben S M, Wei Y F, Pace J L, Hunt J S. TRAIL (Apo-2L) and TRAIL receptors in human placentas: implications for immune privilege. J Immunol 1999; 162: 6053–6059
   PubMed Web of Science ®Google Scholar
• Bamberger A M, Minas V, Kalantaridou S N, Radde J, Sadeghian H, Loning T, Charalampopoulos I, Brummer J, Wagener C, Bamberger C M, Schulte H M, Chrousos G P, Makrigiannakis A. Corticotropin-releasing hormone modulates human trophoblast invasion through carcinoembryonic antigen-related cell adhesion molecule-1 regulation. Am J Pathol 2006; 168: 141–150
   Google Scholar
• Thompson J A, Grunert F, Zimmerman W. Carcinoembryonic antigen gene family: molecular biology and clinical perspectives. J Clin Lab Anal 1991; 5: 344–366
   PubMed Web of Science ®Google Scholar
• Bamberger A M, Sudahl S, Loning T, Wagener C, Bamberger C M, Drakakis P, Coutifaris C, Makrigiannakis A. The adhesion molecule CEACAM1 (CD66a, C-CAM, BGP) is specifically expressed by the extravillous intermediate trophoblast. Am J Pathol 2000; 156: 1165–1170
   Google Scholar
• Bamberger A M, Riethdorf L, Nollau P, Naumann M, Erdmann I, Gotze J, Brummer J, Schulte H M, Wagener C, Loning T. Dysregulated expression of CD66a (BGP, C-CAM), an adhesion molecule of the CEA family, in endometrial cancer. Am J Pathol 1998; 152: 1401–1406
   Google Scholar
• Brosens I A. Morphological changes in the utero-placental bed in pregnancy hypertension. Clin Obstet Gynaecol 1977; 4: 573–593
   PubMed Web of Science ®Google Scholar
• Meekins J W, Pijnenborg R, Hanssens M, McFadyen I R, Van Asshe A. A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br J Obstet Gynaecol 1994; 101: 669–674
   PubMedGoogle Scholar
• Perkins A V, Linton E A, Eben F, Simpson J, Wolfe C D, Redman C W. Corticotropin-releasing hormone and corticotropin-releasing hormone binding protein in normal and pre-eclamptic human pregnancies. Br J Obstet Gynaecol 1995; 102: 118–122
   PubMedGoogle Scholar
• Karteris E, Vatish M, Hillhouse E W, Grammatopoulos D K. Preeclampsia is associated with impaired regulation of the placental nitric oxide-cyclic guanosine monophosphate pathway by corticotropin-releasing hormone (CRH) and CRH-related peptides. J Clin Endocrinol Metab 2005; 90: 3680–3687
   PubMed Web of Science ®Google Scholar
• Grunt M, Glaser J, Schmidhuber H, Pauschinger P, Born J. Effects of corticotropin-releasing factor on isolated rat heart activity. Am J Physiol 1993; 264H: 1124–1129
   Google Scholar
• Gravanis A, Makrigiannakis A, Zoumakis E, Margioris A N. Endometrial and myometrial corticotropin-releasing hormone (CRH): its regulation and possible roles. Peptides 2001; 22: 785–793
   Google Scholar
• Riley S C, Walton J C, Herlick J M, Challis J R. The localization and distribution of corticotropin-releasing hormone in the human placenta and fetal membranes throughout gestation. J Clin Endocrinol Metab 1991; 72: 1001–1007
   PubMed Web of Science ®Google Scholar
• Challis J R, Matthews S G, Van Meir C, Ramirez M M. Current topic: the placental corticotropin-releasing hormone-adrenocorticotrophin axis. Placenta 1995; 16: 481–502
   Google Scholar
• Linton E A, Perkins A V, Woods R J, Eben F, Wolfe C D, Behan D P, Potter E, Vale W W, Lowry P J. Corticotropin releasing hormone-binding protein (CRH-BP): plasma levels decrease during the third trimester of normal human pregnancy. J Clin Endocrinol Metab 1993; 76: 260–262
   PubMed Web of Science ®Google Scholar
• Magiakou M A, Mastorakos G, Rabin D, Dubbert B, Gold P W, Chrousos G P. Hypothalamic corticotropin-releasing hormone suppression during the postpartum period: implications for the increase in-psychiatric manifestations during this time. J Clin Endocrinol Metab 1996; 81: 1912–1917
   PubMed Web of Science ®Google Scholar
• Elenkov I J, Wilder R L, Bakalov V K, Link A A, Dimitrov M A, Fisher S, Crane M, Kanik K S, Chrousos G P. Interleukin 12, tumor necrosis factor-alpha and hormonal changes during late pregnancy and early postpartum: Implications for autoimmune disease activity during these times. J Clin Endocrinol Metab 2001; 86: 4933–4938
   PubMed Web of Science ®Google Scholar
• Grammatopoulos D K, Hillhouse E W. Role of corticotropin-releasing hormone in onset of labour. Lancet 1999; 354: 1546–1549
   PubMed Web of Science ®Google Scholar
• Karalis K, Goodwin G, Majzoub J A. Cortisol blockade of progesterone: a possible molecular mechanism involved in the initiation of human labor. Nat Med 1996; 2: 556–560
   PubMedGoogle Scholar
• Petraglia F, Sutton S, Vale W. Neurotransmitters and peptides modulate the release of immunoreactive corticotropin releasing factor from cultured human placental cells. Am J Obstet Gynecol 1989; 160: 247–251
   PubMed Web of Science ®Google Scholar
• Petraglia F, Garuti G C, De Ramundo B, Angioni S, Genazzani A R, Bilezikjian L M. Mechanism of action of interleukin-1 beta in increasing corticotropin-releasing factor and adrenocorticotropin hormone release from cultured human placental cells. Am J Obstet Gynecol 1990; 163: 1307–1312
   PubMed Web of Science ®Google Scholar
• Robinson B G, Emanuel R L, Frim D M, Majzoub J A. Glucocorticoid stimulates expression of corticotropin-releasing hormone gene in human placenta. Proc Natl Acad Sci USA 1988; 85: 5244–5248
   PubMed Web of Science ®Google Scholar
• Goland R S, Conwell I M, Jozak S. The effect of pre-eclampsia on human placental corticotropin-releasing hormone content and processing. Placenta 1995; 16: 375–382
   PubMedGoogle Scholar
• Ni X, Nicholson R C, King B R, Chan E C, Read M A, Smith R. Estrogen represses whereas the estrogen-antagonist ICI 182780 stimulates placental CRH gene expression. J Clin Endocrinol Metab 2002; 87: 3774–3778
   Google Scholar
• Challis J RG, Matthews S G, Gibb W, Lye S J. Endocrine and paracrine regulation of birth at term and preterm. Endocr Rev 2000; 21: 514–550
   PubMed Web of Science ®Google Scholar
• Wolfe C DA, Patel S P, Linton E A, Campbell E A, Anderson J, Dornhorst A, Lowry P J, Jones M T. Plasma corticotropin-releasing factor (CRF) in abnormal pregnancy. Br J Obstet Gynaecol 1988; 95: 1003–1006
   PubMedGoogle Scholar
• McLean M, Bisits A, Davies J, Woods R, Lowry P, Smith R. A placental clock controlling the length of human pregnancy. Nat Med 1995; 1: 460–463
   PubMed Web of Science ®Google Scholar
• Nielsen D M. Corticotropin-releasing factor type-1 receptor antagonists: the next class of antidepressants?. Life Sci 2006; 78: 909–919
   PubMed Web of Science ®Google Scholar
• Chan E C, Falconer J, Madsen G, Rice K C, Webster E L, Chrousos G P, Smith R. A corticotropin-releasing hormone type 1 receptor antagonist delays parturition in sheep. Endocrinology 1998; 139: 3357–3360
   PubMed Web of Science ®Google Scholar